Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Trial details
- Registry ID
- NCT06274801
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)NCT06274801 | Gossamer Bio USA, Inc. | Phase 3 | Recruiting | 2026-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |